Caylobolide B: Structure Revision, Total Synthesis, Biological Characterization, and Discovery of New Analogues
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.202523117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Malcolm R P George und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK. Hauptthemen laut MEDLINE: Macrolides, Biological Products, Antifungal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The unique potential of marine polyhydroxylated macrolides in chemical biology and drug discovery has long been constrained by their structural complexity and limited material availability, frustrating efforts in stereochemical assignment, synthesis, and mechanism‐of‐action elucidation. Here, we establish an integrated workflow, combining chemogenomic profiling, ultra‐high‐resolution NMR, and modular total synthesis, for the comprehensive functional and structural interrogation of this challenging natural product class. Applying this approach to caylobolides, natural products isolated from scarce samples of Okeania sp., we performed structure‐activity relationship studies revealing that acetylation at C29 markedly reduces both cytotoxicity and antifungal activity, pinpointing a key pharmacophore. Mechanistic profiling suggests that these macrolides disrupt membrane integrity, similar to amantelide A. Using natural compound samples, we simultaneously revised the structure of caylobolide B through 1 H, 1D‐selective TOCSY and HSQC NMR, and developed a modular fragment‐based synthesis of these compounds. By providing a unified methodology for genetic sensitivity profiling, precise structure and stereochemistry determination, and modular total synthesis, this work unlocks new opportunities for the discovery and rational design of potent marine‐derived therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.
- Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, PO Box 100485, Gainesville, FL 32610, USA.
- Smithsonian Marine Station, 701 Seaway Drive, Fort Pierce, FL 34949, USA.
- Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.
ORCID-Profile: Jasper L Tyler, Varinder K Aggarwal
Förderung
- EPSRC
- NIH HHS
- NIGMS NIH HHS
- Bristol Centre for Synthetic Biology
- the University of Florida and
- National Institutes of Health
- Engineering and Physical Sciences Research Council
Zitieren
APA
George, M. R. P., Elsadek, L. A., Deering, M., de Almeida, L. C., Tyler, J. L., Noble, A., Paul, V. J., Luesch, H., Butts, C. P., & Aggarwal, V. K. (2026). Caylobolide B: Structure Revision, Total Synthesis, Biological Characterization, and Discovery of New Analogues. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202523117
Vancouver
George MRP, Elsadek LA, Deering M, de Almeida LC, Tyler JL, Noble A, et al. Caylobolide B: Structure Revision, Total Synthesis, Biological Characterization, and Discovery of New Analogues. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202523117
BibTeX
@article{George2026,
author = {George, Malcolm R P and Elsadek, Lobna A and Deering, Max and de Almeida, Larissa Costa and Tyler, Jasper L and Noble, Adam and Paul, Valerie J and Luesch, Hendrik and Butts, Craig P and Aggarwal, Varinder K},
title = {Caylobolide B: Structure Revision, Total Synthesis, Biological Characterization, and Discovery of New Analogues},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.202523117}
}
EUVIMED